October 01, 2018
WELLESLEY, Mass., Oct. 1, 2018 – Rising demand and US Food and Drug Administration approvals of personalized medicines are major factors driving growth of the protein analysis market. Healthcare R&D spending also plays a significant role. A new BCC Research study projects that this market will reach $19.0 billion in 2023 and examines it by end use, instrumentation and reagents, services and industry type.
Analysis of the entire protein complement of a cell or organism under a given set of conditions is widely used in drug discovery and clinical diagnostics. Additionally, a growing aging population and significant uptick in lifestyle diseases are factors motivating the market. Protein analysis can act as a bridge for drug discovery, customized medicines and biomarkers. From $11.6 billion in 2018, a five-year compound annual growth rate of 10.4% is projected, according to BCC Research’s report Protein Analysis: Subfocus on Oncoproteomics.
Strict regulatory processes for approvals of protein analysis instruments have been one of the major market restraints. In addition, the high costs of these instruments affect their adoption in the industry. Both of these factors could have a negative effect on growth of the protein analysis market.
“National governments have been revising healthcare expenditures to account for increasing R&D. As a result, research institutes will be able to obtain more government funding,” said BCC Research analyst Anuj Pathak. “BGI (China), and the Institute of Bioinformatics and Lab Surgpath (both in India), are major research institutes promoting market growth in the Asia-Pacific region.”
Asia-Pacific Will Exhibit the Fastest Growth
On the basis of geography, the protein analysis market is segmented into North America, Asia-Pacific, Europe, and Rest of the World. During the forecast period, Asia-Pacific will be the fastest-growing region due to its increased protein analysis research activities. North America is still predicted to dominate the global protein analysis market due to high healthcare R&D spending and the growing demand for personalized medicines.
Editors/reporters requesting analyst interviews should contact Eric Surber at firstname.lastname@example.org.
Protein Analysis: Subfocus on Oncoproteomics( BIO168A )
Publish Date: Sep 2018
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.